Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Osiris Therapeutics Inc (NASDAQ:OSIR)

18.73
Delayed Data
As of Aug 28
 +0.59 / +3.25%
Today’s Change
11.87
Today|||52-Week Range
23.67
+17.14%
Year-to-Date
No recent news for Osiris Therapeutics Inc.

Today’s Trading

Previous close18.14
Today’s open18.27
Day’s range17.73 - 18.82
Volume185,916
Average volume (3 months)190,218
Market cap$645.0M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+78.54%
Earnings growth (this year)+520.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+146.29%
P/E ratio149.5
Price/Sales9.15
Price/Book7.66

Competitors

 Today’s
change
Today’s
% change
AGENAgenus Inc+0.35+5.07%
ANIPANI Pharmaceuticals ...+1.91+3.81%
XBITXBiotech Inc+0.63+3.54%
BPMCBlueprint Medicines ...-0.03-0.11%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 6, 2015
EPS forecast (this quarter)$0.06
Annual revenue (last year)$59.9M
Annual profit (last year)-$1.8M
Net profit margin-0.41%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Lode Debrabandere
Chief Financial Officer, Secretary &
Treasurer
Philip R. Jacoby
Corporate headquarters
Columbia, Maryland

Forecasts

Partner Offers